Artal Group’s Unity Biotechnology UBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,000
Closed -$815K 98
2018
Q3
$815K Sell
5,000
-15,000
-75% -$2.45M 0.02% 81
2018
Q2
$3.01M Buy
+20,000
New +$3.01M 0.06% 61